Clinical trial

Fasenra: An Asthma Study

NCT07654842

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2026-07-01

PhasePHASE4

Study timeline

Study start (actual)2026-07-01Date precision: day

Registry last updated2026-09-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Eosinophilic Asthmaunresolved

Severe Asthmaunresolved

Severe Eosinophilic Asthmaunresolved

Asthmaunresolved

Interventions

Budesonide-albuterolDRUG

BenralizumabDRUG

Sponsors & collaborators

Endeavor Healthlead sponsor

AstraZenecacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07654842 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.